Peripheral Artery Disease Market

DelveInsight’s ‘Peripheral Artery Disease Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of PAD and the historical and forecasted PAD market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.


The Peripheral Artery Disease market report provides an overview of PAD, applications of PAD as well as its PEST Analysis. Additionally, the report provides insight on the PAD market share of the individual PAD, current and forecasted PAD market size from 2018 to 2026, segmented by seven major markets. The report also covers the market drivers, market barriers and unmet needs to curate the best of opportunities and assesses underlying potential of the market.

Peripheral Artery Disease Overview

Peripheral Arterial Disease (PAD) is a circulatory problem in which narrowed arteries reduce blood flow to the limbs. When a patient develops PAD, there is lack of blood flow from the required amount. PAD usually occurs in legs or arms. It is also likely to be a sign of a buildup of fatty deposits in arteries. Atherosclerosis may lead to narrowing of arteries and reduce blood flow to legs and, occasionally, arms. The signs and symptoms include painful cramping in one or both of hips, thighs or calf muscles after certain activities, such as walking or climbing stairs, leg numbness or weakness, coldness in lower leg or foot, sores on toes, feet or legs, hair loss or slower hair growth on feet and legs, no pulse or a weak pulse in legs or feet, among others. PAD is relatively common, affecting more than 10 million people in the U.S. It is more common in people who are 65 or older, but can occur at nearly any age.

The endovascular treatment of PAD has seen a marked rise as minimally invasive techniques and devices have been refined. Two newer devices, drug-eluting stents and drug-eluting balloons, are on the forefront of the battle against limb loss from PAD.


Study Period: 2018–2026

Geography Covered

  • The US
  • EU5 (Germany, France, Spain, Italy, and the United Kingdom)
  • Japan

List of Companies:

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Andramed, Terumo Europe NV
  • Cardiovascular Systems Inc.
  • BIOTRONIK, Cardinal Health
  • BD
  • W. L. Gore & Associates, Inc.

Peripheral Artery Disease- Competitive Analysis

This segment of the report provides a brief competitive analysis of PAD, to help understand the competition in the market. It gives a comparative understanding of the products based on types.

Peripheral Artery Disease: Market Segmentation

By Treatment Approach

  • Pharmacological-Based
  • Medical Device-Based


By Product Type

  • Peripheral Angioplasty Balloons (Non-Coated and Drug-Coated)
  • Peripheral Stents (Balloon-Expanding Stents, Drug-Eluting Stents, Self-Expanding Stents, Covered Stents)
  • Arthrectomy Devices (Directional, Rotational, Photoablative, and Orbital)


By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Peripheral Artery Disease: Market Dynamics

Market Drivers

  • The increase in geriatric population base.
  • The rapid advancements in product development.


Market Barriers

  • High product pricing.
  • Product-related safety concerns in people with comorbidities.

Peripheral Artery Disease: Market Analysis

This segment illustrates the market of PAD across the 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.

KOL Views

To keep up with the market trends, we take KOLs and SME’s opinion working in PAD domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or PAD market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of PAD, explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available PAD is provided, which will have an impact on the future market of PAD.
  • A detailed review of PAD market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the PAD market.

Report Highlights

  • The report covers descriptive overview of the PAD, explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the PAD market.
  • The report also reviews the detailed historical and forecasted PAD market, including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the PAD market.

Peripheral Artery Disease Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • PEST Analysis
  • Market Size

Peripheral Artery Disease Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Key Questions

Market Insights:

  • What was the PAD market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the PAD total market size as well as market size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across the 7MM and which country will have the largest PAD market size during the forecast period (2018–2026)?
  • At what CAGR, the PAD market is expected to grow in the 7MM during the forecast period (2018–2026)?
  • What will be the PAD market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the PAD market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the PAD market?
  • What are the PAD available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing PAD?
  • What are the key collaborations (Industry–Industry), mergers and acquisitions, licensing activities related to the PAD?
  • What are the key designations that have been granted for the current PAD?
  • What are the 7MM countries historical and forecasted market of PAD?

Frequently Asked Questions

What is Peripheral Artery Disease?

Peripheral Arterial Disease (PAD) is a circulatory problem in which narrowed arteries reduce blood flow to the limbs. When a patient develops PAD, there is lack of blood flow from the required amount.


How is Peripheral Artery Disease Market Segmented?

The Peripheral Artery Disease is segmented on the basis by Treatment Approach, by Product Type and by End User.


Who are the leading companies in Peripheral Artery Disease Market Landscape?

The leading companies that are working in the Peripheral Artery Disease Market are Abbott, Medtronic, Boston Scientific Corporation, Andramed, Terumo Europe NV, Cardiovascular Systems Inc., BIOTRONIK, Cardinal Health, BD, W. L. Gore & Associates, Inc. and many others.


What are the Peripheral Artery Disease Market Drivers?

The market driver is increase in geriatric population base and the rapid advancements in product development.


What are the Peripheral Artery Disease Market Barriers?

The market barrier is high product pricing and product-related safety concerns in people with comorbidities.


What are the key strengths of Peripheral Artery Disease Market Report?

Key strengths of Peripheral Artery Disease Market Report are 6 Years Forecast, 7MM Coverage, Competitive Landscape, PEST Analysis, Market Size, Market Drivers and Market Barriers.


What is the Impact of COVID-19 on Peripheral Artery Disease Market?

The Peripheral Artery Disease Market had observed a positive shift in market revenues due to the COVID 19 in 2020. The report includes the factors that are contributing to this significant increase in detail.

1. Key Insights

2. Executive Summary of Peripheral Artery Disease

3. Peripheral Artery Disease: Background and Overview

3.1. Introduction

3.2. Types of Peripheral Artery Disease

3.3. Advantages of Peripheral Artery Disease

3.4. Disadvantages of Peripheral Artery Disease

4. Peripheral Artery Disease: Regulatory Scenario

5. Peripheral Artery Disease: Reimbursement Scenario

6. Company Profiles

6.1. Medtronic

6.1.1. Company Overview

6.1.2. Product Portfolio

6.1.2.1. Product description

6.1.2.2. Regulatory Milestones

6.1.2.3. Research and Development

6.1.2.4. Product Development Activities

6.2. Abbott

6.2.1. Company Overview

6.2.2. Product Portfolio

6.2.2.1. Product description

6.2.2.2. Regulatory Milestones

6.2.2.3. Research and Development

6.2.2.4. Product Development Activities

More Companies in the final report…

7. Peripheral Artery Disease: Competitive Analysis

8. KOL Views

9. Peripheral Artery Disease: Market Analysis in 7MM

9.1. Peripheral Artery Disease: Market Analysis in 7MM by Treatment Approach (2018–2026)

9.2. Peripheral Artery Disease: Market Analysis in 7MM by Product Type (2018–2026)

9.3. Peripheral Artery Disease: Market Analysis in 7MM by End User (2018–2026)

10. Country-Wise Market size of Peripheral Artery Disease in 7MM (2018–2026)

10.1. Market size of Peripheral Artery Disease in the United States

10.1.1. Peripheral Artery Disease: Market Analysis in the United States by Treatment Approach (2018–2026)

10.1.2. Peripheral Artery Disease: Market Analysis in the United States by Product Type (2018–2026)

10.1.3. Peripheral Artery Disease: Market Analysis in the United States by End User (2018–2026)

10.2. Market size of Peripheral Artery Disease in Germany

10.2.1. Peripheral Artery Disease: Market Analysis in Germany by Treatment Approach (2018–2026)

10.2.2. Peripheral Artery Disease: Market Analysis in Germany by Product Type (2018–2026)

10.2.3. Peripheral Artery Disease: Market Analysis in Germany by End User (2018–2026)

10.3. Market size of Peripheral Artery Disease in France

10.3.1. Peripheral Artery Disease: Market Analysis in France by Treatment Approach (2018–2026)

10.3.2. Peripheral Artery Disease: Market Analysis in France by Product Type (2018–2026)

10.3.3. Peripheral Artery Disease: Market Analysis in France by End User (2018–2026)

10.4. Market size of Peripheral Artery Disease in Spain

10.4.1. Peripheral Artery Disease: Market Analysis in Spain by Treatment Approach (2018–2026)

10.4.2. Peripheral Artery Disease: Market Analysis in Spain by Product Type (2018–2026)

10.4.3. Peripheral Artery Disease: Market Analysis in Spain by End User (2018–2026)

10.5. Market size of Peripheral Artery Disease in Italy

10.5.1. Peripheral Artery Disease: Market Analysis in Italy by Treatment Approach (2018–2026)

10.5.2. Peripheral Artery Disease: Market Analysis in Italy by Product Type (2018–2026)

10.5.3. Peripheral Artery Disease: Market Analysis in Italy by End User (2018–2026)

10.6. Market size of Peripheral Artery Disease in UK

10.6.1. Peripheral Artery Disease: Market Analysis in UK by Treatment Approach (2018–2026)

10.6.2. Peripheral Artery Disease: Market Analysis in UK by Product Type (2018–2026)

10.6.3. Peripheral Artery Disease: Market Analysis in UK by End User (2018–2026)

10.7. Market size of Peripheral Artery Disease in Japan

10.7.1. Peripheral Artery Disease: Market Analysis in Japan by Treatment Approach (2018–2026)

10.7.2. Peripheral Artery Disease: Market Analysis in Japan by Product Type (2018–2026)

10.7.3. Peripheral Artery Disease: Market Analysis in Japan by End User (2018–2026)

11. Market Dynamics

11.1. Market Drivers

11.2. Market Barriers

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix

14.1. Bibliography

14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

17. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: Peripheral Artery Disease Market Analysis in the 7MM (2018–2026)

Table 3: Peripheral Artery Disease Market Analysis in the 7MM by Treatment Approach (2018–2026)

Table 4: Peripheral Artery Disease Market Analysis in the 7MM by Product Type (2018–2026)

Table 5: Peripheral Artery Disease Market Analysis in the 7MM by End User (2018–2026)

Table 6: Peripheral Artery Disease United States Market Analysis (2018–2026)

Table 7: Peripheral Artery Disease Market Analysis in the US by Treatment Approach (2018-2026)

Table 8: Peripheral Artery Disease Market Analysis in the US by Product Type (2018-2026)

Table 9: Peripheral Artery Disease Market Analysis in the US by End User (2018-2026)

Table 10: Peripheral Artery Disease Germany Market Analysis (2018–2026)

Table 11: Peripheral Artery Disease Market Analysis in Germany by Treatment Approach (2018-2026)

Table 12: Peripheral Artery Disease Market Analysis in Germany by Product Type (2018-2026)

Table 13: Peripheral Artery Disease Market Analysis in Germany by End User (2018-2026)

Table 14: Peripheral Artery Disease France Market Analysis (2018–2026)

Table 15: Peripheral Artery Disease Market Analysis in France by Treatment Approach (2018-2026)

Table 16: Peripheral Artery Disease Market Analysis in France by Product Type (2018-2026)

Table 17: Peripheral Artery Disease Market Analysis in France by End User (2018-2026)

Table 18: Peripheral Artery Disease Spain Market Analysis (2018–2026)

Table 19: Peripheral Artery Disease Market Analysis in Spain by Treatment Approach (2018-2026)

Table 20: Peripheral Artery Disease Market Analysis in Spain by Product Type (2018-2026)

Table 21: Peripheral Artery Disease Market Analysis in Spain by End User (2018-2026)

Table 22: Peripheral Artery Disease Italy Market Analysis (2018–2026)

Table 23: Peripheral Artery Disease Market Analysis in Italy by Treatment Approach (2018-2026)

Table 24: Peripheral Artery Disease Market Analysis in Italy by Product Type (2018-2026)

Table 25: Peripheral Artery Disease Market Analysis in Italy by End User (2018-2026)

Table 26: Peripheral Artery Disease United Kingdom Market Analysis (2018–2026)

Table 27: Peripheral Artery Disease Market Analysis in the UK by Treatment Approach (2018-2026)

Table 28: Peripheral Artery Disease Market Analysis in the UK by Product Type (2018-2026)

Table 29: Peripheral Artery Disease Market Analysis in the UK by End User (2018-2026)

Table 30: Peripheral Artery Disease Japan Market Analysis (2018–2026)

Table 31: Peripheral Artery Disease Market Analysis in Japan by Treatment Approach (2018-2026)

Table 32: Peripheral Artery Disease Market Analysis in Japan by Product Type (2018-2026)

Table 33: Peripheral Artery Disease Market Analysis in Japan by End User (2018-2026)

List of Figures

Figure 1: Competitive Analysis

Figure 2: Peripheral Artery Disease Market Analysis in the 7MM (2018–2026)

Figure 3: Peripheral Artery Disease Market Analysis in the 7MM by Treatment Approach (2018–2026)

Figure 4: Peripheral Artery Disease Market Analysis in the 7MM by Product Type (2018–2026)

Figure 5: Peripheral Artery Disease Market Analysis in the 7MM by End User (2018–2026)

Figure 6: Peripheral Artery Disease United States Market Analysis (2018–2026)

Figure 7: Peripheral Artery Disease Market Analysis in the US by Treatment Approach (2018-2026)

Figure 8: Peripheral Artery Disease Market Analysis in the US by Product Type (2018-2026)

Figure 9: Peripheral Artery Disease Market Analysis in the US by End User (2018-2026)

Figure 10: Peripheral Artery Disease Germany Market Analysis (2018–2026)

Figure 11: Peripheral Artery Disease Market Analysis in Germany by Treatment Approach (2018-2026)

Figure 12: Peripheral Artery Disease Market Analysis in Germany by Product Type (2018-2026)

Figure 13: Peripheral Artery Disease Market Analysis in Germany by End User (2018-2026)

Figure 14: Peripheral Artery Disease France Market Analysis (2018–2026)

Figure 15: Peripheral Artery Disease Market Analysis in France by Treatment Approach (2018-2026)

Figure 16: Peripheral Artery Disease Market Analysis in France by Product Type (2018-2026)

Figure 17: Peripheral Artery Disease Market Analysis in France by End User (2018-2026)

Figure 18: Peripheral Artery Disease Spain Market Analysis (2018–2026)

Figure 19: Peripheral Artery Disease Market Analysis in Spain by Treatment Approach (2018-2026)

Figure 20: Peripheral Artery Disease Market Analysis in Spain by Product Type (2018-2026)

Figure 21: Peripheral Artery Disease Market Analysis in Spain by End User (2018-2026)

Figure 22: Peripheral Artery Disease Italy Market Analysis (2018–2026)

Figure 23: Peripheral Artery Disease Market Analysis in Italy by Treatment Approach (2018-2026)

Figure 24: Peripheral Artery Disease Market Analysis in Italy by Product Type (2018-2026)

Figure 25: Peripheral Artery Disease Market Analysis in Italy by End User (2018-2026)

Figure 26: Peripheral Artery Disease United Kingdom Market Analysis (2018–2026)

Figure 27: Peripheral Artery Disease Market Analysis in the UK by Treatment Approach (2018-2026)

Figure 28: Peripheral Artery Disease Market Analysis in the UK by Product Type (2018-2026)

Figure 29: Peripheral Artery Disease Market Analysis in the UK by End User (2018-2026)

Figure 30: Peripheral Artery Disease Japan Market Analysis (2018–2026)

Figure 31: Peripheral Artery Disease Market Analysis in Japan by Treatment Approach (2018-2026)

Figure 32: Peripheral Artery Disease Market Analysis in Japan by Product Type (2018-2026)

Figure 33: Peripheral Artery Disease Market Analysis in Japan by End User (2018-2026)

Figure 34: Market Drivers

Figure 35: Market Barriers

Abbott, Medtronic

Boston Scientific Corporation

Andramed, Terumo Europe NV

Cardiovascular Systems Inc.

BIOTRONIK, Cardinal Health

BD

W. L. Gore & Associates, Inc.

  • Tags:
  • Peripheral Artery Disease Companies
  • Peripheral Artery Disease
  • Peripheral Artery DiseaseMarket
  • Peripheral Artery Disease Industry
  • Peripheral Artery Disease Treatmen...
  • Peripheral Artery Disease Market S...
  • PAD market share
  • PAD treatment devices

Forward to Friend

Need A Quote